BIO.News Newsletter

Today, we let our international affairs team take over Good Day BIO, to share a little bit about some of BIO’s important international work on COVID-19 and how BIO members are working with companies around the world on vaccines and treatments. (Read through to the end to get to more news from the United States, too.) Here are 830 words, or 4 minutes, 10 seconds.

It's a new month. Today, we're taking a look at recent misguided decisions by the EPA, as well as a must-listen radio interview with BIO CEO Jim Greenwood on what the industry's doing about coronavirus and why the drug pricing debate still matters. Here are 800 words, about 4 minutes.

We missed National Doctors Day yesterday, so we want to give a special shoutout to the doctors, nurses, and other medical professionals on the frontlines of the COVID-19 battle, putting themselves and their families in danger to save patients’ lives. We’re working hard to bring you the diagnostics, treatments, vaccines, and supplies you and your patients need, as quickly as possible. Today, we’re taking a quick look at the impact of COVID-19 on clinical trials, as well as an example of…

It’s another Monday in lockdown—but we have promising developments from a few member companies. First, we have a new episode of the I AM BIO Podcast, with insight on when we’ll have a COVID-19 vaccine. Second, another company is using synthetic biology to manufacture sustainable, moisturizing hand sanitizer—which you can actually order now—as well as a vaccine ingredient. Here are just under 900 words, or about 4-and-a-half minutes, to start your week.

It’s Friday. As we close a busy week, and prepare for another one ahead, here’s a 680-word read (3 and a half minutes) on our new survey with BioCentury on how COVID-19 is affecting clinical trials—and some thoughts on the industry’s incredible work to collaborate.

Getting this email for the first time? Welcome! We’ve expanded Good Day BIO’s distribution to all BIO members. We value your participation and want to ensure you’ve got the latest information on activities in the biotech space during this critically important time. We welcome your questions and feedback. Today, we’ve got about 860 words (4 minutes) on what happened during BIO’s virtual coronavirus summit and an example of a small biotech at the intersection of agriculture and health working on…

It's Wednesday – Day 2 of BIO’s COVID-19 virtual summit. The event kicked off yesterday, featuring biotech innovators, leading academics and government agencies on the frontlines of the rapidly evolving coronavirus public health crisis. Roughly 45 BIO members working on treatments, diagnostics and vaccines joined government officials including Ambassador Deborah Birx and Dr. Robert Kadlec for a robust discussion about the most effective approaches to respond to pandemics.In other news, we take…

We know you’ve heard it many times by now, but in case you need a reminder: even young people are being hospitalized with COVID-19. So, just stay inside, cook some fresh, healthy vegetables, and keep on Zooming. Today, we’re taking a look at another, equally urgent health threat—superbugs—as well as how ethanol plants are helping to meet the demand for hand sanitizer, in around 780 words, just under 4 minutes.

It’s Monday. We hope you were able to find a little enjoyment and peace over the weekend. Today, we have the perfect thing for your solitary walks in the park: a new episode of the I AM BIO Podcast, taking a look at Regeneron's innovative work to treat COVID-19 symptoms. And as discussions continue on the Hill about the coronavirus bailout package, we have some thoughts about the role of Sustainable Aviation Fuels and the intersection of the economy, climate change, and public health.Here are…

It’s Friday. Check out what we’re doing to help the industry collaborate and find COVID-19 cures as quickly as possible, as well as a new law in Maine that will support the biobased economy. Here are 825 words, around 4 minutes.